
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
Jiří Zahradník, Shir Marciano, Maya Shemesh, et al.
Nature Microbiology (2021) Vol. 6, Iss. 9, pp. 1188-1198
Open Access | Times Cited: 379
Jiří Zahradník, Shir Marciano, Maya Shemesh, et al.
Nature Microbiology (2021) Vol. 6, Iss. 9, pp. 1188-1198
Open Access | Times Cited: 379
Showing 26-50 of 379 citing articles:
Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function
Darren P. Martin, Spyros Lytras, Alexander G. Lucaci, et al.
Molecular Biology and Evolution (2022) Vol. 39, Iss. 4
Open Access | Times Cited: 110
Darren P. Martin, Spyros Lytras, Alexander G. Lucaci, et al.
Molecular Biology and Evolution (2022) Vol. 39, Iss. 4
Open Access | Times Cited: 110
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 108
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 108
Recurrent SARS-CoV-2 mutations in immunodeficient patients
Samuel Wilkinson, Alex Richter, Anna Casey, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 105
Samuel Wilkinson, Alex Richter, Anna Casey, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 105
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 103
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 103
SARS-CoV-2 evolution in the Omicron era
Cornelius Roemer, Daniel J. Sheward, Ryan Hisner, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1952-1959
Closed Access | Times Cited: 79
Cornelius Roemer, Daniel J. Sheward, Ryan Hisner, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1952-1959
Closed Access | Times Cited: 79
Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant
Vineet Sharma, Himanshu Rai, Dev Nath Singh Gautam, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1876-1885
Open Access | Times Cited: 78
Vineet Sharma, Himanshu Rai, Dev Nath Singh Gautam, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1876-1885
Open Access | Times Cited: 78
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Maren Schubert, Federico Bertoglio, Stephan Steinke, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Maren Schubert, Federico Bertoglio, Stephan Steinke, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
Kenrie P. Y. Hui, Ka‐Chun Ng, John CW Ho, et al.
EBioMedicine (2022) Vol. 83, pp. 104232-104232
Open Access | Times Cited: 76
Kenrie P. Y. Hui, Ka‐Chun Ng, John CW Ho, et al.
EBioMedicine (2022) Vol. 83, pp. 104232-104232
Open Access | Times Cited: 76
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 75
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 75
Virological characteristics of the SARS-CoV-2 BA.2.86 variant
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 170-180.e12
Open Access | Times Cited: 63
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 170-180.e12
Open Access | Times Cited: 63
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
Population immunity predicts evolutionary trajectories of SARS-CoV-2
Matthijs Meijers, Denis Ruchnewitz, Jan Eberhardt, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5151-5164.e13
Open Access | Times Cited: 50
Matthijs Meijers, Denis Ruchnewitz, Jan Eberhardt, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5151-5164.e13
Open Access | Times Cited: 50
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Joseph F. Standing, Laura Buggiotti, José Afonso Guerra‐Assunção, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Joseph F. Standing, Laura Buggiotti, José Afonso Guerra‐Assunção, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Implications of diversity in sperm size and function for sperm competition and fertility
Montserrat Gomendio, Eduardo R. S. Roldán
The International Journal of Developmental Biology (2008) Vol. 52, Iss. 5-6, pp. 439-447
Open Access | Times Cited: 182
Montserrat Gomendio, Eduardo R. S. Roldán
The International Journal of Developmental Biology (2008) Vol. 52, Iss. 5-6, pp. 439-447
Open Access | Times Cited: 182
Genomic reconstruction of the SARS-CoV-2 epidemic in England
Harald Vöhringer, Theo Sanderson, Matthew Sinnott, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 506-511
Open Access | Times Cited: 102
Harald Vöhringer, Theo Sanderson, Matthew Sinnott, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 506-511
Open Access | Times Cited: 102
Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load
Jorge Quarleri, Verónica Galván, M. Victoria Delpino
GeroScience (2021) Vol. 44, Iss. 1, pp. 53-56
Open Access | Times Cited: 72
Jorge Quarleri, Verónica Galván, M. Victoria Delpino
GeroScience (2021) Vol. 44, Iss. 1, pp. 53-56
Open Access | Times Cited: 72
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 71
Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 71
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 69
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 69
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain
Nathaniel L. Miller, Thomas A. Clark, Rahul Raman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100527-100527
Open Access | Times Cited: 67
Nathaniel L. Miller, Thomas A. Clark, Rahul Raman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100527-100527
Open Access | Times Cited: 67
SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 65
Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 65
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 65
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 65
The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
Nicholas E. Ingraham, David H. Ingbar
Clinical and Translational Medicine (2021) Vol. 11, Iss. 12
Open Access | Times Cited: 64
Nicholas E. Ingraham, David H. Ingbar
Clinical and Translational Medicine (2021) Vol. 11, Iss. 12
Open Access | Times Cited: 64
Virological characteristics of SARS-CoV-2 BA.2 variant
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 63
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 63
A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19
Faheem Ahmed, Afaque Manzoor Soomro, Abdul Rahim Chethikkattuveli Salih, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113350-113350
Open Access | Times Cited: 61
Faheem Ahmed, Afaque Manzoor Soomro, Abdul Rahim Chethikkattuveli Salih, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113350-113350
Open Access | Times Cited: 61
Molecular basis of cross‐species ACE2 interactions with SARS‐CoV‐2‐like viruses of pangolin origin
Sheng Niu, Jia Wang, Bin Bai, et al.
The EMBO Journal (2021) Vol. 40, Iss. 16
Open Access | Times Cited: 59
Sheng Niu, Jia Wang, Bin Bai, et al.
The EMBO Journal (2021) Vol. 40, Iss. 16
Open Access | Times Cited: 59